Article
Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
The Journal of steroid biochemistry and molecular biology - 1 Mar 1997
Levenson A S, Catherino W H, Jordan V C
Abstract excerpt
The estrogen receptor (ER) functions as a ligand-activated transcription factor which mediates the actions of estrogens and antiestrogens in target tissues. Other investigators have shown that artificial point mutations in the transcriptional activation domain AF-2 of the ligand binding domain (LBD) of the ER can increase the estrogenic properties of antiestrogens, determined by transcriptional activation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
